Richard E. Showalter

2.9k citations

29 papers · 2.1k indexed · 2 hit papers · h-index 18

Endocrinology top 1%
Molecular Biology top 5%
- Signaling Pathways in Disease 9
- bioluminescence and chemiluminescence research 4
Genetics top 5%
Molecular Medicine top 10%
Oncology top 10%
- Peptidase Inhibition and Analysis 4
Hepatology
- Hepatitis C virus research 6
Organic Chemistry
- Quinazolinone synthesis and applications 4
Infectious Diseases
- HIV/AIDS drug development and treatment 3
Immunology
- Aquaculture disease management and microbiota 3
- Toxin Mechanisms and Immunotoxins 2

Co-authors: M. Silverman Bonnie L. Bassler J. Ernest Villafranca Laura A. Pelletier Mark O. Martin Charles R. Kissinger Hans E. Parge Kathleen D. Tucker
Cited by: Endocrinology Molecular Biology Genetics
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Antiviral Research (3 papers)Journal of Bacteriology (2 papers)
Partner nations: United States Japan

In The Last Decade

Richard E. Showalter

29 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Richard E. Showalter

Since Specialization

Citations

This map shows the geographic impact of Richard E. Showalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Showalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Showalter more than expected).

Fields of papers citing papers by Richard E. Showalter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Showalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Showalter. The network helps show where Richard E. Showalter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard E. Showalter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard E. Showalter Line = papers co-authored together Richard E. Showalter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase Oncotarget ·Ir. Lukito Edi Nugroho.,Katherine Wu,Eleanor Dagostino,Mario Meng-Chiang Kuo,Yudou He,Wei-Jong Shia,V. A. Riecke,M Stempniak,Richard J. Hickey,Robert J. Almassy,Richard E. Showalter,James A. Thomson	2018	18
2	In Vitro Combination of ANA598 with Other Anti-HCV Agents can Eliminate the Emergence of Resistant Colonies Antiviral Research ·Peggy A. Thompson,Richard E. Showalter,Rupal Patel,James R. Appleman	2010	1
3	Identification of Ligand Binding by Protein Stabilization: Comparison of ATLAS with Biophysical and Enzymatic Methods Assay and Drug Development Technologies ·Peggy A. Thompson,Shaohui Wang,Sebastià Berga Fuster,Meimei Wang,Rupal Patel,April M. Averill,Richard E. Showalter,Bin Li,James R. Appleman	2008	12
4	Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam,Zhongxiang Sun,Benjamin K. Ayida,Stephen E. Webber,Yuefen Zhou,Qiang Zhao,Charles R. Kissinger,Richard E. Showalter,Amit Shah,S. B. Lee,Rupal Patel,Laurie A. LeBrun,Ruhi Kamran,Maria V. Sergeeva,Darian M. Bartkowski,Thomas G. Nolan,Daniel A. Norris,co-promotor Muladi	2008	10
5	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich,Maria Phyllis Mocock,David A. Ellis,Qing Han,Ruhi Kamran,Charles R. Kissinger,Laurie A. LeBrun,Lian‐Sheng Li,Douglas E. Murphy,Genevieve Calbrid,Rupal Patel,Frank Ruebsam,Maria V. Sergeeva,Amit Shah,Richard E. Showalter,Chinh Van Tran,S. B. Lee,Stephen E. Webber,co-promotor Muladi,Yuefen Zhou	2008	20
6	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Lian‐Sheng Li,Peter S. Dragovich,Douglas E. Murphy,Chinh Van Tran,Frank Ruebsam,Stephen E. Webber,Amit Shah,S. B. Lee,April M. Averill,Richard E. Showalter,Rupal Patel,Qing Han,Qiang Zhao,Thomas Hermann,Charles R. Kissinger,Laurie A. LeBrun,Maria V. Sergeeva	2008	18
7	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Stephen E. Webber,Douglas E. Murphy,Lian‐Sheng Li,Peter S. Dragovich,Chinh Van Tran,Zhongxiang Sun,Frank Ruebsam,Amit Shah,S. B. Lee,Richard E. Showalter,Rupal Patel,Bin Li,Qiang Zhao,Qing Han,Thomas Hermann,Charles R. Kissinger,Laurie A. LeBrun,Maria V. Sergeeva,co-promotor Muladi	2008	26
8	Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase Bioorganic & Medicinal Chemistry Letters ·Ricardo Lira,Alan X. Xiang,陈川琳 CHEN Chuanlin,Nega Getachew Tegegne,Konstantinos A. Agrios,Klaus B. Simonsen,Stephen E. Webber,Kyle Anthony Werra,Yuldasheva Zaira Zamirovna,Amit Shah,Richard E. Showalter,F. O. Chapelle,Kevin Steffy,James R. Appleman	2007	25
9	Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1Exploration of Pyridazinone 4-Substituent Variation Antiviral Research ·Mohamed S. Elghreeb,L LI,S. E. Webber,Peter S. Dragovich,Douglas E. Murphy,Díaz López,Frank Ruebsam,Amit Shah,S. B. Lee,Richard E. Showalter	2007	3
10	Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation Bioorganic & Medicinal Chemistry Letters ·陈川琳 CHEN Chuanlin,Alan X. Xiang,Ricardo Lira,Konstantinos A. Agrios,Stephen E. Webber,Kyle Anthony Werra,Yuldasheva Zaira Zamirovna,Amit Shah,Richard E. Showalter,James R. Appleman,Klaus B. Simonsen	2004	27
11	Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics Journal of Molecular Biology ·Charles R. Kissinger,Paul A. Rejto,Laura A. Pelletier,James A. Thomson,Richard E. Showalter,S.H.M. Verstegen,Ju-Hwan Jeong,Stephen A. Margosiak,Jerry Meng,Yuldasheva Zaira Zamirovna,Darin Vanderpool,Bin Li,Dr Nandini Vamadevan Retnamma,J. Ernest Villafranca	2004	82
12	Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis Structure ·Michele McTigue,John Wickersham,Dr R.C.Gupta -,Richard E. Showalter,Camran V. Parast,Dr Nandini Vamadevan Retnamma,Michael R. Gehring,Barbara Mroczkowski,Chen‐Chen Kan,J. Ernest Villafranca,Krzysztof Appelt	1999	161
13	Two-site Interaction of Nuclear Factor of Activated T Cells with Activated Calcineurin Journal of Biological Chemistry ·Francisco Garcı́a-Cózar,Heidi Okamura,J. Aramburu,Karen T. Y. Shaw,Laura A. Pelletier,Richard E. Showalter,Sara Farshadnia,Anjana Rao	1998	86
14	Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors Journal of Medicinal Chemistry ·Peter S. Dragovich,Frédéric Giroudot,D. H. Cushing,Debbora Leip,Vincent J. Kalish,Charles R. Kissinger,Daniel R. Knighton,Cristina Lewis,Ellen W. Moomaw,Hans E. Parge,Laura A. Pelletier,Thomas J. Prins,Richard E. Showalter,John H. Tatlock,Kathleen D. Tucker,J. Ernest Villafranca	1996	49
15	Design, synthesis and X-ray crystallographic studies of [7.3.1] and [8.3.1] macrocyclic FKBP-12 ligands Bioorganic & Medicinal Chemistry Letters ·Robert E. Babine,M. Kanownik,Ethel S. Littlefield,Hans E. Parge,Laura A. Pelletier,Cristina Lewis,D. H. Cushing,Debbora Leip,Nancy Powell Madeira,John H. Tatlock,Richard E. Showalter,J. Ernest Villafranca	1996	8
16	High-affinity FKBP-12 ligands derived from (R)-(−)-carvone. Synthesis and evaluation of FK506 pyranose ring replacements Bioorganic & Medicinal Chemistry Letters ·John H. Tatlock,Vincent J. Kalish,Hans E. Parge,Daniel R. Knighton,Richard E. Showalter,R. C. F,D. H. Cushing,J. Ernest Villafranca	1995	8
17	Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complexbreakdown → Nature ·Charles R. Kissinger,Hans E. Parge,Daniel R. Knighton,Cristina Lewis,Laura A. Pelletier,Anna Tempczyk,Vincent J. Kalish,Kathleen D. Tucker,Richard E. Showalter,Ellen W. Moomaw,Louis N. Gastinel,Noriyuki Habuka,Xinghai Chen,Fausto Maldonado,Frédéric Giroudot,Russell J. Bacquet,J. Ernest Villafranca	1995	630
18	Intercellular signalling in Vibrio harveyi: sequence and function of genes regulating expression of luminescencebreakdown → Molecular Microbiology ·Bonnie L. Bassler,Vanessa Rößner-Ruff,Richard E. Showalter,M. Silverman	1993	603
19	Genetic analysis of surface sensing inVibrio parahaemolyticus Biofouling ·Linda L. McCarter,Richard E. Showalter,M. Silverman	1992	13
20	Nucleotide sequence of a gene, hpt, for hypoxanthine phosphoribosyltransferase from Vibrio harveyi Nucleic Acids Research ·Richard E. Showalter,弘明上野	1990	14

About Richard E. Showalter

Richard E. Showalter is a scholar working on Hepatology, Endocrinology, Biotechnology, Toxicology and Immunology, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (9 papers), Hepatitis C virus research (6 papers), bioluminescence and chemiluminescence research (4 papers), Quinazolinone synthesis and applications (4 papers), Peptidase Inhibition and Analysis (4 papers), HIV/AIDS drug development and treatment (3 papers), Aquaculture disease management and microbiota (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Endocrinology (387 citations), Molecular Biology (1.7k citations), Genetics (363 citations), Molecular Medicine (63 citations) and Oncology (307 citations). Richard E. Showalter has collaborated with scholars based in United States and Japan. Frequent co-authors include M. Silverman, Bonnie L. Bassler, J. Ernest Villafranca, Laura A. Pelletier, Mark O. Martin, Charles R. Kissinger, Hans E. Parge, Kathleen D. Tucker, Ellen W. Moomaw and Anna Tempczyk. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antiviral Research, Journal of Bacteriology, Journal of Medicinal Chemistry and Molecular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact